Vaccine Adjuvants Market Segmentation:
Product Type Segment Analysis
The global vaccine adjuvants market is segmented and analyzed for demand and supply by product type into adjuvant emulsions, pathogen components, saponin-based adjuvants, particulate adjuvants and others. Out of these, the adjuvant emulsions segment is estimated to gain the largest vaccine adjuvants market share of about 29% in the year 2035. The increasing demand for adjuvant emulsions in the vaccine market owing to their capability to enhance the efficacy of the vaccine, as well as the rising awareness about the importance of immunization among the population are major factors driving the growth of this segment. For instance, a number of emulsion adjuvants have been used in commercially available influenza vaccines, such as MF59 and AS03, and their composition and performance have been extensively studied and reported. Moreover, increasing government initiatives to promote the use of adjuvant-containing vaccines to reduce the cost of the vaccine delivery system and enhance the overall efficiency of the vaccine are also contributing to the growth of this segment.
Route of Administration Segment Analysis
The global vaccine adjuvants market is segmented and analyzed for demand and supply by route of administration into intramuscular, subcutaneous, oral route and others. Out of these, the intramuscular segment is estimated to gain the significant vaccine adjuvants market share of about 37% in the year 2035. The intramuscular route of administration is becoming increasingly popular among the patient population owing to its ability to provide a more sustained release of the vaccine, thereby improving the efficiency of the vaccine. Research has shown that 30 to 50% of intended intramuscular injections succeed, with the remainder resulting in inadvertent subcutaneous drug placement. Additionally, intramuscular injections are considered to be less painful than other routes of administration, making them more desirable for patients. These factors are anticipated to create numerous opportunities for the growth of the segment in the coming years.
Our in-depth analysis of the global vaccine adjuvants market includes the following segments:
|
By Product Type |
|
|
By Route of Administration |
|
|
By Disease Type |
|
|
By Application |
|
|
By Application Category |
|
